IRFAN A. ASANGANI – PH.D.

Assistant Professor of Cancer Biology
Assistant Investigator, Abramson Family Cancer Research Institute

Faculty Webpage

http://www.cbio.med.upenn.edu/bioTemplate.asp?pageID=7

Contact Information

Perelman School of Medicine at the University of Pennsylvania
Department of Cancer Biology
Abrasion Family Cancer Research Institute
421 Curie Boulevard
611 BRB II/III
Philadelphia, PA 19104-6160
Office: (215)746-8780
Fax: (215)573-6725
asangani@pennmedicine.upenn.edu

Publication Links

Research Interest

Cancer cells display an altered landscape of chromatin leading to broad changes in the gene expression. In addition, genes involved in chromatin remodeling and epigenetic regulation are frequently and specifically mutated in a wide variety of cancers including prostate cancer. While known to serve important roles in the control of gene expression and development, these largely unexpected mutation findings have illuminated newly recognized mechanisms central to the genesis of cancer. Gaining insight into the mechanism of chromatin regulation in cancer will offer the potential to reveal novel approaches and targets for effective therapeutic intervention.

Our laboratory employs a multidisciplinary approach to study these molecular epigenetic events associated with cancer towards the overarching goal of translating this knowledge into clinical tools by developing novel diagnostic, prognostic and therapeutic strategies. Additionally, we investigate the mechanisms of resistance to targeted therapies and develop novel combinatorial approaches that act on compensatory/new pathways in resistant tumors. Our basic strategy is to develop and deploy rational polytherapy upfront that suppresses the survival and emergence of resistant tumor cells.